Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Arthur C. DeGraff"'
Autor:
David W. Hudgel, Sheldon R. Braun, Eugene R. Bleecker, Michael C. Boyars, Arthur C. Degraff, Donald P. Tashkin, Sammy Campbell, Steven A. Sahn
Publikováno v:
The American Journal of Medicine. 100:S62-S69
The efficacy, persistence of bronchodilator action, and safety of the quaternary ammonium anticholinergic agent, ipratropium bromide (500 microgram), and placebo were compared when each was added in solution form to the beta-adrenergic agonist soluti
Autor:
Arthur C. DeGraff
Publikováno v:
Chest. 122:392-394
Publikováno v:
American heart journal. 31
Autor:
D. Robert Webb, Stuart M. Garay, Jeffrey Leflein, Joe W. Ramsdell, Michael Noonan, J Grossman, William Berger, George W. Bensch, Anthony R. Rooklin, David F. Graft, Arthur C. DeGraff, Judy E. Harrison, Richard G. Gower, Lucy Shneyer, Evangelo Frigas, Keith B. Nolop, Jill P. Karpel, Eric J. Schenkel, Robert A. Nathan, Bernard Silverman, David I. Bernstein, Edwin A. Bronsky, Timothy J. Craig, James E. Fish
Publikováno v:
The Journal of allergy and clinical immunology. 106(5)
Inhaled corticosteroid therapy in severe persistent asthma has been shown to reduce or eliminate oral corticosteroid (OCS) use while retaining effective asthma control.We sought to evaluate the ability of mometasone furoate (MF) delivered by means of
Autor:
David A. Stevens, Howard J. Schwartz, Jeannette Y. Lee, Bruce L. Moskovitz, Dennis C. Jerome, Antonino Catanzaro, David M. Bamberger, Allison J. Weinmann, Carmelita U. Tuazon, Marc A. Judson, Thomas A.E. Platts-Mills, Jay Grossman, Raymond G. Slavin, Peter Reuman, Arthur C. DeGraff
Publikováno v:
The New England journal of medicine. 342(11)
Allergic bronchopulmonary aspergillosis is a hypersensitivity disorder that can progress from an acute phase to chronic disease. The main treatment is systemic corticosteroids, but data from uncontrolled studies suggest that itraconazole, an orally a
Autor:
David S. Pearlman, Teresa Arledge, Edmundo Stahl, Mary Beth Welch, Thomas G. O’Riordan, Yonghua Wang, James P. Kemp, Arthur C. DeGraff, Myra Rosario Herrle
Publikováno v:
The Journal of allergy and clinical immunology. 104(6)
Background: Long-acting β 2 -sympathomimetic agonists such as salmeterol have been proved safe and effective for the treatment of asthma. However, controversy still exists as to the appropriateness of scheduled long-term therapy with these agents. O
Publikováno v:
American Heart Journal. 93:117-120
Summary The beta blocking agents are valuable drugs in cardiology. They are effective in any fast arrhythmia. Together with nitroglycerin, beta blockers are drugs of first choice in angina. As antihypertensives, they have advantages that should make
Publikováno v:
Journal of Asthma. 23:309-319
In order to evaluate whether adverse reactions to a nonsteroidal antiinflammatory agent (NSAIA) were related to variations in prostaglandin levels during the menstrual cycle, we measured 13-14-diOH-15-keto-prostaglandin F2 alpha in serum and the effe
Publikováno v:
American Heart Journal. 94:517-528
Publikováno v:
American Heart Journal. 92:661-664
The cardiovascular alpha adrenergic receptors evoke vasoconstriction, the cardiovascular beta receptors evoke vasodilation and cardiac stimulation. All blood vessels have both alpha and beta receptors. In some areas, for example skin and kidney, the